Cost-effectiveness of hepatitis A vaccination in Indonesia

References

• David AM, Steering Committee for Prevention and Control of Infectious Diseases. Hepatitis A outbreaks--methods of intervention in South-East Asian countries. Int J Infect Dis 2004; 8:201 - 9; http://dx.doi.org/10.1016/j.ijid.2003.09.005; PMID: 15234323
   PubMed Web of Science ®Google Scholar
• Luyten J, Beutels P. Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A. Pharmacoeconomics 2009; 27:379 - 89; http://dx.doi.org/10.2165/00019053-200927050-00003; PMID: 19586076
   PubMed Web of Science ®Google Scholar
• World Gastroenterology Organization. Management of acute viral hepatitis. 2007: 1-23. Available from: http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/02_acute_hepatitis.pdf
   Google Scholar
• Barzaga BN. Hepatitis A shifting epidemiology in South-East Asia and China. Vaccine 2000; 18:Suppl 1 S61 - 4; http://dx.doi.org/10.1016/S0264-410X(99)00467-3; PMID: 10683551
   PubMed Web of Science ®Google Scholar
• Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010; 28:6653 - 7; http://dx.doi.org/10.1016/j.vaccine.2010.08.037; PMID: 20723630
   PubMed Web of Science ®Google Scholar
• Luyten J, Van de Sande S, de Schrijver K, Van Damme P, Beutels P. Cost-effectiveness of hepatitis A vaccination for adults in Belgium. Vaccine 2012; 30:6070 - 80; http://dx.doi.org/10.1016/j.vaccine.2012.07.049; PMID: 22858555
   PubMed Web of Science ®Google Scholar
• Vranckx R, Alisjahbana A, Deville W, Meheus A. Hepatitis A antibodies in Indonesian neonates and children. Int J Infect Dis 1997; 2:31 - 3; http://dx.doi.org/10.1016/S1201-9712(97)90008-4
   Google Scholar
• Suwantika AA, Yegenoglu S, Riewpaiboon A, Tu HA, Postma MJ. Economic evaluations of hepatitis A vaccination in middle-income countries. Expert Rev Vaccines 2013; 12:1479 - 94; http://dx.doi.org/10.1586/14760584.2013.851008; PMID: 24168129
   PubMed Web of Science ®Google Scholar
• Wilopo SA, Kilgore P, Kosen S, Soenarto Y, Aminah S, Cahyono A, Ulfa M, Tholib A. Economic evaluation of a routine rotavirus vaccination programme in Indonesia. Vaccine 2009; 27:Suppl 5 F67 - 74; http://dx.doi.org/10.1016/j.vaccine.2009.09.040; PMID: 19931723
   PubMed Web of Science ®Google Scholar
• The World Bank. GDP per capita. Available from the website: http://data.worldbank.org/indicator/NY.GDP.PCAP.CD
   Google Scholar
• Walker DG1, Hutubessy R, Beutels P. . WHO guide for standardization of economic evaluations of immunization programmes. Vaccine 2010; 28:2356 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.06.035; PMID: 19567247
   PubMed Web of Science ®Google Scholar
• Pham B, Duval B, De Serres G, Gilca V, Tricco AC, Ochnio J, Scheifele DW. Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review. BMC Infect Dis 2005; 5:56; http://dx.doi.org/10.1186/1471-2334-5-56; PMID: 16001978
   PubMed Web of Science ®Google Scholar
• Zhuang GH, Pan XJ, Wang XL. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China. Vaccine 2008; 26:4608 - 16; http://dx.doi.org/10.1016/j.vaccine.2008.05.086; PMID: 18597903
   PubMed Web of Science ®Google Scholar
• Anonychuk AM, Tricco AC, Bauch CT, Pham B, Gilca V, Duval B, John-Baptiste A, Woo G, Krahn M. Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies. Pharmacoeconomics 2008; 26:17 - 32; http://dx.doi.org/10.2165/00019053-200826010-00003; PMID: 18088156
   PubMed Web of Science ®Google Scholar
• Beutels P, Luyten J, Lejeune O, Hens N, Blicke J, De Schrijver K, Van de Sande S, Van Herck K, Van Damme P. Evaluation of universal and targeted hepatitis A vaccination programs in Belgium. Health Technology Assessment (HTA). Brussels: Belgian Health Care Knowledge Centre (KCE); 2008. 176p. KCE reports 98A (D/2008/http://dx.doi.org/10.273/88). Available from the website: https://kce.fgov.be/sites/default/files/page_documents/d20081027388.pdf.
   Google Scholar
• Beutels P, MacIntyre CR, McIntyre P. Cost-effectiveness of childhood hepatitis A vaccination in Australia. Paper presented at 5th World Congress of the International Health Economics Association, Barcelona, Spain, 9-12 July 2005.
   Google Scholar
• Ellis A, Rüttimann RW, Jacobs RJ, Meyerhoff AS, Innis BL. Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted. Rev Panam Salud Publica 2007; 21:345 - 56; http://dx.doi.org/10.1590/S1020-49892007000500002; PMID: 17761046
   PubMed Web of Science ®Google Scholar
• Valenzuela MT, Jacobs RJ, Arteaga O, Navarrete MS, Meyerhoff AS, Innis BL. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile. Vaccine 2005; 23:4110 - 9; http://dx.doi.org/10.1016/j.vaccine.2005.03.021; PMID: 15964479
   PubMed Web of Science ®Google Scholar
• Teppakdee A, Tangwitoon A, Khemasuwan D, Tangdhanakanond K, Suramaethakul N, Sriratanaban J, Poovorawan Y. Cost-benefit analysis of hepatitis a vaccination in Thailand. Southeast Asian J Trop Med Public Health 2002; 33:118 - 27; PMID: 12118439
   PubMedGoogle Scholar
• Sartori AMC, de Soárez PC, Novaes HMD, Amaku M, de Azevedo RS, Moreira RC, Pereira LM, Ximenes RA, Martelli CM. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context. Vaccine 2012; 30:7489 - 97; http://dx.doi.org/10.1016/j.vaccine.2012.10.056; PMID: 23107593
   PubMed Web of Science ®Google Scholar
• O’Connor JB, Imperiale TF, Singer ME. Cost-effectiveness analysis of hepatitis A vaccination strategies for adults. Hepatology 1999; 30:1077 - 81; http://dx.doi.org/10.1002/hep.510300422; PMID: 10498662
   PubMed Web of Science ®Google Scholar
• Quezada A, Baron-Papillon F, Coudeville L, Maggi L. Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study. Rev Panam Salud Publica 2008; 23:303 - 12; http://dx.doi.org/10.1590/S1020-49892008000500002; PMID: 18510790
   PubMed Web of Science ®Google Scholar
• Lopez E, Debbag R, Coudeville L, Baron-Papillon F, Armoni J. The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health-economic analysis. J Gastroenterol 2007; 42:152 - 60; http://dx.doi.org/10.1007/s00535-006-1984-x; PMID: 17351805
   PubMed Web of Science ®Google Scholar
• Freiesleben de Blasio B, Flem E, Latipov R, Kuatbaeva A, Kristiansen IS. Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan. Emerg Infect Dis 2014; 20:29 - 37; http://dx.doi.org/10.3201/eid2001.130019; PMID: 24378188
   PubMed Web of Science ®Google Scholar
• Soogarun S, Wiwanitkit V. Vaccinating Thai adolescents against hepatitis A: is it cost-effective?. Southeast Asian J Trop Med Public Health 2002; 33:Suppl 3 145 - 8; PMID: 12971496
   PubMedGoogle Scholar
• SABIN. Indonesia: Government expenditures on routine immunization, vaccines and health. Available from: http://www.sabin.org/sites/sabin.org/files/Indonesia.pdf
   Google Scholar
• Murdoch DL, Goa K, Figgitt DP. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability. Drugs 2003; 63:2625 - 49; http://dx.doi.org/10.2165/00003495-200363230-00008; PMID: 14636084
   PubMed Web of Science ®Google Scholar
• The World Bank. Life expectancy at birth. Available from: http://data.worldbank.org/indicator/SP.DYN.LE00.IN
   Google Scholar
• Buma AH, Beutels P, van Damme P, Tormans G, van Doorslaer E, Leentvaar-Kuijpers A. An economic evaluation of hepatitis A vaccination in Dutch military personnel. Mil Med 1998; 163:564 - 7; PMID: 9715622
   PubMed Web of Science ®Google Scholar
• Water and Sanitation Program East Asia and The Pacific (WSP-EAP), The World Bank. Economic impacts of sanitation in Indonesia. 2008: 1-89. Available from the website: http://www.wsp.org/sites/wsp.org/files/publications/esi_indonesia.pdf
   Google Scholar
• Gaol DPL. The overview of hepatitis A at Hasan Sadikin Hospital Bandung period 1 January 2011-31 December 2011. Bachelor thesis. Maranatha Christian University, Faculty of Medicine; 2013.
   Google Scholar
• Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD. Cost-utility of universal hepatitis A vaccination in Canada. Vaccine 2007; 25:8536 - 48; http://dx.doi.org/10.1016/j.vaccine.2007.10.001; PMID: 17996339
   PubMed Web of Science ®Google Scholar
• Ren A, Feng F, Ma J, Xu Y, Liu C. Immunogenicity and safety of a new inactivated hepatitis A vaccine in young adults: a comparative study. Chin Med J (Engl) 2002; 115:1483 - 5; PMID: 12490092
   PubMed Web of Science ®Google Scholar
• Yin WD. The Healive™ inactivated domestic hepatitis A vaccine: production and application. Chin J Vaccines Immun 2004; 10:174 - 7
   Google Scholar
• Liu CB, Ren YH, Zhang YC, Wu WT, Li SP, Kang WX, et al. The study on immunogenicity, safety and vaccination schedule of a new inactivated hepatitis A vaccine in Chinese children. Chin J Vaccines Immun 2002; 8:1 - 3
   Google Scholar
• Jacobs RJ, Meyerhoff AS, Zink T. Hepatitis A immunization strategies: universal versus targeted approaches. Clin Pediatr (Phila) 2005; 44:705 - 9; http://dx.doi.org/10.1177/000992280504400809; PMID: 16211195
   PubMed Web of Science ®Google Scholar
• Levin CE, Nelson CM, Widjaya A, Moniaga V, Anwar C. The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia. Bull World Health Organ 2005; 83:456 - 61; PMID: 15976897
   PubMed Web of Science ®Google Scholar
• Jacobs RJ, Moleski RJ, Meyerhoff AS. Valuation of symptomatic hepatitis a in adults: estimates based on time trade-off and willingness-to-pay measurement. Pharmacoeconomics 2002; 20:739 - 47; http://dx.doi.org/10.2165/00019053-200220110-00003; PMID: 12201793
   PubMed Web of Science ®Google Scholar
• Postma MJ, Jit M, Rozenbaum MH, Standaert B, Tu HAT, Hutubessy RC. Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world. BMC Med 2011; 9:84; http://dx.doi.org/10.1186/1741-7015-9-84; PMID: 21740545
   PubMed Web of Science ®Google Scholar
• The World Bank. PPP conversion factor. Available from the website: http://data.worldbank.org/indicator/PA.NUS.PPP?page=
   Google Scholar